X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES UNICHEM LAB ALKEM LABORATORIES/
UNICHEM LAB
 
P/E (TTM) x - -64.1 - View Chart
P/BV x 7.1 0.7 989.8% View Chart
Dividend Yield % 0.6 2.4 25.9%  

Financials

 ALKEM LABORATORIES   UNICHEM LAB
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
UNICHEM LAB
Mar-18
ALKEM LABORATORIES/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,589382 416.0%   
Low Rs1,232234 526.3%   
Sales per share (Unadj.) Rs417.5116.3 359.0%  
Earnings per share (Unadj.) Rs56.3-18.9 -297.5%  
Cash flow per share (Unadj.) Rs64.7-11.7 -551.1%  
Dividends per share (Unadj.) Rs12.705.00 254.0%  
Dividend yield (eoy) %0.91.6 55.5%  
Book value per share (Unadj.) Rs292.9381.0 76.9%  
Shares outstanding (eoy) m119.5770.34 170.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.42.6 127.6%   
Avg P/E ratio x25.1-16.3 -153.9%  
P/CF ratio (eoy) x21.8-26.2 -83.1%  
Price / Book Value ratio x4.80.8 595.6%  
Dividend payout %22.6-26.4 -85.4%   
Avg Mkt Cap Rs m168,65321,668 778.3%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m9,1712,006 457.1%   
Avg. sales/employee Rs ThNM3,587.8-  
Avg. wages/employee Rs ThNM880.0-  
Avg. net profit/employee Rs ThNM-583.7-  
INCOME DATA
Net Sales Rs m49,9158,180 610.2%  
Other income Rs m1,645610 269.6%   
Total revenues Rs m51,5618,790 586.6%   
Gross profit Rs m8,482-1,320 -642.5%  
Depreciation Rs m1,006505 199.1%   
Interest Rs m67180 837.2%   
Profit before tax Rs m8,451-1,295 -652.4%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,60633 4,805.5%   
Profit after tax Rs m6,731-1,331 -505.8%  
Gross profit margin %17.0-16.1 -105.3%  
Effective tax rate %19.0-2.6 -736.5%   
Net profit margin %13.5-16.3 -82.9%  
BALANCE SHEET DATA
Current assets Rs m27,06223,318 116.1%   
Current liabilities Rs m15,3244,635 330.6%   
Net working cap to sales %23.5228.4 10.3%  
Current ratio x1.85.0 35.1%  
Inventory Days Days67122 54.6%  
Debtors Days Days41121 34.0%  
Net fixed assets Rs m12,6108,163 154.5%   
Share capital Rs m239141 169.9%   
"Free" reserves Rs m34,49026,660 129.4%   
Net worth Rs m35,02726,801 130.7%   
Long term debt Rs m1,2123 36,715.2%   
Total assets Rs m54,38731,890 170.5%  
Interest coverage x13.6-15.2 -89.7%   
Debt to equity ratio x00 28,092.9%  
Sales to assets ratio x0.90.3 357.8%   
Return on assets %13.6-3.9 -347.0%  
Return on equity %19.2-5.0 -387.0%  
Return on capital %24.9-4.5 -547.3%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,5634,356 150.7%   
Fx outflow Rs m3,0120-   
Net fx Rs m3,5524,356 81.5%   
CASH FLOW
From Operations Rs m7,259-1,123 -646.1%  
From Investments Rs m1,86416,487 11.3%  
From Financial Activity Rs m-9,273-8,811 105.2%  
Net Cashflow Rs m-1506,552 -2.3%  

Share Holding

Indian Promoters % 66.9 50.1 133.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 15.1 219.2%  
FIIs % 0.0 3.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 31.7 -  
Shareholders   68,381 20,176 338.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   PLETHICO PHARMA  BIOCON LTD  J.B.CHEMICALS  NATCO PHARMA  AJANTA PHARMA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Sep 21, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS